Skip to main content
PMC home page
BMC Complementary and Alternative Medicine logoLink to BMC Complementary and Alternative Medicine
. 2012 Apr 20;12:49. doi: 10.1186/1472-6882-12-49

In vitro antiplasmodial, antileishmanial and antitrypanosomal activities of selected medicinal plants used in the traditional Arabian Peninsular region

Nawal M Al-Musayeib 1, Ramzi A Mothana 1,✉, An Matheeussen 2, Paul Cos 2, Louis Maes 2
PMCID: PMC3493369  PMID: 22520595

Abstract

Background

Worldwide particularly in developing countries, a large proportion of the population is at risk for tropical parasitic diseases. Several medicinal plants are still used traditionally against protozoal infections in Yemen and Saudi Arabia. Thus the present study investigated the in vitro antiprotozoal activity of twenty-five plants collected from the Arabian Peninsula.

Methods

Plant materials were extracted with methanol and screened in vitro against erythrocytic schizonts of Plasmodium falciparum, intracellular amastigotes of Leishmania infantum and Trypanosoma cruzi and free trypomastigotes of T. brucei. Cytotoxic activity was determined against MRC-5 cells to assess selectivity. The criterion for activity was an IC50 < 10 μg/ml (<5 μg/ml for T. brucei) and selectivity index of >4.

Results

Antiplasmodial activity was found in the extracts of Chrozophora oblongifolia, Ficus ingens, Lavandula dentata and Plectranthus barbatus. Amastigotes of T. cruzi were affected by Grewia erythraea, L. dentata, Tagetes minuta and Vernonia leopoldii. Activity against T. brucei was obtained in G. erythraea, L. dentata, P. barbatus and T. minuta. No relevant activity was found against L. infantum. High levels of cytotoxicity (MRC-5 IC50 < 10 μg/ml) and hence non-specific activities were noted in Cupressus sempervirens, Kanahia laniflora and Kniphofia sumarae.

Conclusion

The results endorse that medicinal plants can be promising sources of natural products with antiprotozoal activity potential. The results support to some extent the traditional uses of some plants for the treatment of parasitic protozoal diseases.

Background

Today over one billion people worldwide are at risk for tropical diseases caused by parasitic organisms. The World Health Organization (WHO) now classifies many as neglected tropical diseases, having an enormous impact on socioeconomic development and quality of life at all levels particularly in developing countries [1]. At present, a lot of research is committed to leishmaniasis, malaria, Chagas disease and sleeping sickness, not only because they are major killing diseases but also because disease control becomes more difficult due to a number of factors that limit the utility of current drugs in resource-poor settings, such as high cost, poor compliance, drug resistance, low efficacy and poor safety [2]. Hence, the search for new and preferably cheap drugs needs to be continued [3].

Natural products are still major potential sources of innovative therapeutic agents for various conditions, including infectious diseases as they represent an unmet source of chemical diversity [4]. Indeed, several antiparasitic drugs have been derived directly from natural sources, such as quinine, artemisinin and atovaquone as antimalarials and amphotericin B as antileishmanial drug.

It is estimated that two thirds of the world population still rely on traditional medical remedies, mainly plants, because of limited availability and affordability of pharmaceutical medicines [5]. This explains why a lot of current research focuses on natural molecules and plant-derived products as they can be sourced easily, are locally available and can be selected on the basis of their ethnomedicinal use [6].

In this study, 25 plants were selected from the flora of Yemen and Saudi Arabia, and subjected to a broad panel of in vitro antiparasitic assays in an attempt to identify plant species with a promising antiprotozoal in vitro activity profile and could be subject for further investigations.

Methods

Plant materials

Twenty five plants (Table 1) were selected randomly from different areas of Yemen and Saudi Arabia in March and Jun 2008 and identified at the Pharmacognosy Departments, Colleges of Pharmacy, King Saud and Sana'a Universities, Saudi Arabia and Yemen. The plants were selected mainly on the basis of their local medicinal knowledge. Voucher specimens were deposited at departments. The botanical names, plant part used and the traditional uses of the plants in the collected areas are presented in Table 1.

Table 1.

List of plants screened and their traditional uses

Plant species Voucher specimen no. Family Part used Traditional uses
Ajuga bracteosa Wall. ex Benth.
 Mo-I10a
 Labiatae
 L, F
 As antiseptic and for teeth pains, stimulant, diuretic and in treatment of rheumatism, gout, palsy, amenorrhea and malaria a,b
Caralluma quadrangula (Forssk.) N.E.Br.
 Mo-H02a
 Asclepiadaceae
 L
 For diabetes, stomachic ulcer and smallpox a, c
Centaurea pseudosinaica Czerep.
 Mo-S11a
 Asteraceae
 L, T
 For wounds and kidney diseases a
Chrozophora oblongifolia (Del.) A.
Juss. ex Spreng.
 Mo-S02a
 Euphorbiacea
 L, S
 As antiseptic for wounds, antimicrobial, cathartic, emetic and hypoglycemic and for hemorrhoids a, d
Costus arabicus L.
 Mo-S05a
 Zingiberaceae
 R
 For cancers a
Cupressus sempervirens L.
 Mo-S25a
 Cupressaceae
 L
 As expectorant, astringent and for wounds, diarrhea, hemorrhoids a, c
Dodonaea viscosa (L.) Jacq.
 Mo-T01a
 Sapindaceae
 L, S
 For malaria, wounds and burns, gout , rheumatism and as anesthetic, laxative and tonic a, c, e, f,
Dorstenia barnimiana Schweinf.
 Mo-T09
 Moraceae
 L, S
 For the treatment of fungal and skin diseases a, c
Enicostemma verticillare (Retz.) Baill.
 Mo-I06a
 Gentianaceae
 L
 For diabetes a
Ficus cordata ssp. Salicifolia
 15133
 Moraceae
 L, S
 For the treatment of filariasis, diarrheal infections, tuberculosis and oral infections a, c
Ficus ingens (Miq.)
 15187
 Moraceae
 L, S
 For Piles, diarrhea, and as diuretic a
Ficus palmata Forssk
 15163
 Moraceae
 L, S
 For constipation and lungs and bladder diseases a, c
Grewia erythraea Schweinf.
 Mo-S07a
 Tiliaceae
 L, S
 As Diuretic and haemostatic and for kidney diseases a
Iris albicans Lange
 Mo-I02a
 Iridaceae
 R
 For rheumatism and gout a
Kanahia laniflora (Forsk.) R. Br.
 Mo-I19a
 Asclepiadaceae
 L, T
 For tumors, skin diseases, scabies and itching a, c, h
Kniphofia sumarae Deflers
 Mo-I10a
 Liliaceae
 R
 For malaria a
Lavandula dentata L.
 Mo-I11a
 Labiatae
 L, F
 For wounds, rheumatism, urine retention, and kidney stones and as antiseptic a, d
Leucas inflata Benth.
 Mo-I05a
 Labiatae
 L, F
 For kidney diseases and tooth ache a
Pulicaria inuloides DC.
 Mo-M05a
 Asteraceae
 L, F
 For wounds and as antiseptic a
Plectranthus barbatus Andr.
 15732a
 Labiatae
 L, S
 For stomachache, nausea, gastritis, intestinal spasms, burns, wounds, sores, insect bites, allergies, ringworms, infections, malaria and break fevers a, f
Rhus retinorrhaea Steud. ex Oliv.
 Mo-T22a
 Anacardiaceae
 L
 General tonic and for painful joints a
Tagetes minuta L.
 YT-20a
 Asteraceae
 L, S
 As antimicrobial, anthelmintic, diuretic, and antispasmodic agent a, f
Tarconanthus camphoratus L
 Mo-S15a
 Asteraceae
 L, T
 For wounds and for urinary tract infections a
Teucrium yemense Deflers
 Mo-S17a
 Labiatae
 L, F
 For kidney diseases, rheumatism and diabetes a, d
Vernonia leopoldii Vatke Mo-T16a Asteraceae L, F For cough, colic and skin diseases a, h
Open in a new tab

F Flower, L Leaves, R Roots or rhizomes, S Stems, T Fruits.

a information has been taken from native people.

b Chandel S, Bagai U, 2010 [7].

c Al-Dubai and Al-Khulaidi (1996) [8].

d Atiqur-Rahman et al., (2004) [9].

e Mossa et al., (1987) [10].

f Ali et al., (2004) [11].

g Fleurentin and Pelt (1982) [12].

h Schopen (1983) [13].

Extraction of plant materials

The air-dried and powdered plant material (50 g) was extracted with 500 ml methanol (CH3OH) by using a Soxhlet apparatus for 8 hours. The obtained methanol extract was filtered and evaporated by using a rotatory evaporator and freeze dryer. The dried extracts were stored at −20°C until used. Stock solutions were prepared in 100% DMSO at 20 mg/ml just prior to screening.

Reference drugs

For the different tests, appropriate reference drugs were used as positive control: tamoxifen for MRC-5, chloroquine for P. falciparum, miltefosine for L. infantum, benznidazole for T. cruzi and suramin for T. b. brucei. All reference drugs were either obtained from the fine chemical supplier Sigma or from WHO-TDR.

Biological assays

The integrated panel of microbial screens and standard screening methodologies were adopted as previously described [14]. All assays were performed in triplicate (first test in duplicate and a single independent repeat) at the Laboratory of Microbiology, Parasitology and Hygiene at the University of Antwerp, Belgium. Plant extracts were tested at 5 concentrations (64, 16, 4, 1 and 0.25 μg/ml) to establish a full dose-titration and determination of the IC50 (inhibitory concentration 50%). The concentration of DMSO did not exceed 0.5%. The selectivity of action was assessed by simultaneous evaluation of cytotoxicity on a fibroblast (MRC-5) cell line. The criterion for activity was an IC50 < 10 μg/ml (< 5 μg/ml for T. brucei) and a selectivity index of > 4.

Antileishmanial activity

L.infantum MHOM/MA(BE)/67 amastigotes were collected from the spleen of an infected donor hamster and used to infect primary peritoneal mouse macrophages. To determine in vitro antileishmanial activity, 3 × 104 macrophages were seeded in each well of a 96-well plate. After 2 days outgrowth, 5 × 105 amastigotes/well were added and incubated for 2 h at 37°C. Pre-diluted plant extracts were subsequently added and the plates were further incubated for 5 days at 37°C and 5% CO2. Parasite burdens (mean number of amastigotes/macrophage) were microscopically assessed after Giemsa staining, and expressed as a percentage of the blank controls without plant extract.

Antiplasmodial activity

Chloroquine-resistant P. falciparum 2/K 1-strain was cultured in human erythrocytes O+ at 37°C under a low oxygen atmosphere (3% O2, 4% CO2, and 93% N2) in RPMI-1640, supplemented with 10% human serum. Infected human red blood cells (200 μl, 1% parasitaemia, 2% haematocrit) were added to each well and incubated for 72 h. After incubation, test plates were frozen at −20°C. Parasite multiplication was measured by the Malstat method [14,15].

Antitrypanosomal activity

Trypanosoma brucei Squib-427 strain (suramin-sensitive) was cultured at 37°C and 5% CO2 in Hirumi-9 medium [16], supplemented with 10% fetal calf serum (FCS). About 1.5 × 104 trypomastigotes/well were added to each well and parasite growth was assessed after 72 h at 37°C by adding resazurin [17]. For Chagas disease, T. cruzi Tulahuen CL2 (benznidazole-sensitive) was maintained on MRC-5 cells in minimal essential medium (MEM) supplemented with 20 mM L-glutamine, 16.5 mM sodium hydrogen carbonate and 5% FCS. In the assay, 4 × 103 MRC-5 cells and 4 × 104 parasites were added to each well and after incubation at 37°C for 7 days, parasite growth was assessed by adding the β-galactosidase substrate chlorophenol red β-D-galactopyranoside [18]. The color reaction was read at 540 nm after 4 h and absorbance values were expressed as a percentage of the blank controls.

Cytotoxicity assay

MRC-5 SV2 cells were cultivated in MEM, supplemented with L-glutamine (20 mM), 16.5 mM sodium hydrogen carbonate and 5% FCS. For the assay, 104 MRC-5 cells/well were seeded onto the test plates containing the pre-diluted sample and incubated at 37°C and 5% CO2 for 72 h. Cell viability was assessed fluorimetrically after 4 hours of addition of resazurin. Fluorescence was measured (excitation 550 nm, emission 590 nm) and the results were expressed as % reduction in cell viability compared to control.

Results

Crude methanol extracts from 25 plant species belonging to 18 families that are used in Arabian traditional medicine, were evaluated in the integrated in vitro screen for antileishmanial, antiplasmodial and antitrypanosomal potential (Table 2). Only 7 extracts exhibited relevant activity (acceptable potency and selectivity) in one or more models (Table 2).

Table 2.

Antiprotozoal activity of the methanol extracts of the investigated plants and their cytotoxicity against MRC-5 cell lines

Plant species P. falciparum
  
 L. infantum
  
 T. cruzi
  
 T. brucei
  
 MRC-5
IC50 SI IC50 SI IC50
(μg/ml) 		SI IC50 SI IC50
Ajuga bracteosa
 >64.0
 >1
 >64.0
 >1
 28.8 ± 4.6
 >2.22
 31.2 ± 5.2
 >2.05
 >64.0
Caralluma quadrangula
 27.5 ± 4.3
 >2.33
 >64.0
 >1
 >64.0
 >1
 32.5 ± 6.5
 >1.97
 >64.0
Centaurea pseudosinaica
 48.2 ± 9.8
  
 32.5 ± 3.5
  
 31.0 ± 6.1
  
 9.1 ± 1.8
 1.76
 16.0 ± 5.3
Chrozophora oblongifolia
 5.0 ± 1.2
 12.80
 27.3 ± 2.8
 2.34
 32.0 ± 5.8
 >2
 10.8 ± 2.4
 5.93
 >64.0
Costus arabicus
 >64.0
  
 27.3 ± 3.1
 1.41
 13.8 ± 2.1
 2.79
 30.0 ± 4.9
 1.28
 38.5 ± 8.2
Cupressus sempervirens
 7.6 ± 2.4
 1.41
 2.0 ± 0.4
 5.35
 8.3 ± 1.9
 1.29
 2.1 ± 0.2
 5.10
 10.7 ± 3.1
Dorstenia barnimiana
 34.2 ± 8.7
 1.44
 >64.0
  
 29.6 ± 3.9
 1.67
 22.6 ± 5.8
 2.19
 49.4 ± 9.1
Dodonaea viscosa
 46.7 ± 11.8
 >1.37
 45.3 ± 11.8
 1.41
 >64.0
 >1
 11.1 ± 1.8
 5.77
 >64.0
Enicostemma verticillare
 >64.0 ±
 >1
 >64.0
 >1
 >64.0
 >1
 9.9 ± 1.1
 >6.46
 >64.0
Ficus cordata ssp.salicifolia
 27.0 ± 6.9
 1.20
 27.3 ± 6.1
 1.19
 26.3 ± 3.2
 1.24
 8.2 ± 1.9
 3.96
 32.5 ± 7.3
Ficus ingens
 8.4 ± 2.3
 3.87
 32.5 ± 7.2
 1.00
 31.2 ± 4.3
 1.04
 8.0 ± 2.2
 4.06
 32.5 ± 7.5
Ficus palmata
 14.5 ± 3.8
 2.60
 >64.0
  
 22.6 ± 4.0
 1.67
 8.1 ± 2.6
 4.65
 37.7 ± 6.9
Grewia erythraea
 11.7 ± 3.5
 2.32
 24.1 ± 3.8
 1.13
 8.2 ± 1.8
 3.32
 2.6 ± 0.9
 10.46
 27.2 ± 6.1
Iris albicans
 55.5 ± 6.2
 >1.15
 >64.0
 >1
 >64.0
 >1
 10.6 ± 3.1
 >6.04
 >64.0
Kanahia laniflora
 27.9 ± 4.9
  
 >64.0
  
 0.4 ± 0.2
 2.00
 9.6 ± 3.0
  
 0.8 ± 0.2
Kniphofia sumarae
 1.3 ± 0.6
 5.69
 32.5 ± 4.9
  
 31.4 ± 3.4
  
 5.9 ± 2.8
 1.25
 7.4 ± 1.4
Lavandula dentata
 7.1 ± 1.4
 4.17
 20.3 ± 3.5
 1.46
 7.9 ± 0.5
 3.75
 3.0 ± 1.8
 9.87
 29.6 ± 5.9
Leucas inflata
 44.6 ± 6.3
  
 >64.0
  
 >64.0
  
 8.4 ± 2.2
 3.51
 29.5 ± 6.0
Plectranthus barbatus
 6.5 ± 2.0
 5.06
 24.1 ± 2.9
 1.37
 23.3 ± 2.9
 1.41
 2.6 ± 1.8
 12.65
 32.9 ± 6.8
Pulicaria inuloides
 21.6 ± 3.8
 >2.96
 45.3 ± 8.3
 1.41
 31.7 ± 4.0
 >2.02
 7.8 ± 2.1
 >8.21
 >64.0
Rhus retinorrhaea
 37.1 ± 4.9
 1.43
 >64.0
  
 30.5 ± 3.9
 1.74
 34.0 ± 5.8
 1.56
 53.2 ± 7.2
Tagetes minuta
 14.0 ± 2.8
 4.57
 30.1 ± 4.6
 >2.13
 9.2 ± 1.9
 >6.96
 2.2 ± 1.5
 >29.09
 >64.0
Tarconanthus camphoratus
 >64.0
 >1
 >64.0
 >1
 >64.0
 >1
 >64.0
 >1
 >64.0
Teucrium yemense
 12.5 ± 2.6
 2.18
 32.5 ± 6.6
  
 30.5 ± 2.9
  
 7.1 ± 2.3
 3.83
 27.2 ± 5.3
Vernonia leopoldii
 41.9 ± 7.9
  
 27.3 ± 5.1
 1.10
 9.2 ± 1.2
 3.27
 8.0 ± 2.9
 3.76
 30.1 ± 4.9
Chloroquine
 0.3 ± 0.1
  
 -
  
 -
  
 -
  
 -
Miltefosine
 -
  
 3.32 ± 0.7
  
 -
  
 -
  
 -
Benznidazole
 -
  
 -
  
 2.2 ± 0.5
  
 -
  
 -
Suramin
 -
  
 -
  
 -
  
 0.03 ± 0.02
  
 -
Tamoxifen -   -   -   -   11.0 ± 2.3
Open in a new tab

IC50 values of reference drugs are expressed in μM/ml concentrations.

Antimalarial activity

In this study, the methanol extract of Chrozophora oblongifolia exhibited the greatest activity against P. falciparum with an IC50 value of 5.0 μg/ml and a high SI value of 12.8. Furthermore, the extract of three other plants (Ficus ingens, Lavandula dentata and Plectranthus barbatus) showed activity against P. falciparum with IC50 8.4, 7.1 and 6.5 μg/ml respectively. These extracts exhibited moderate SI values of 3.8, 4.1 and 5.1, respectively.

Antileishmanial activity

No relevant results were found against L. infantum. A very marginal activity was observed for C. oblongifolia, Costus arabicus, Grewia erythraea, L. dentata, P. barbatus, and Vernonia leopoldii with IC50 values between 20.3 and 27.3 μg/ml and low SI values between 1.0 and 2.5.

Antitrypanosomal activity

Our screen demonstrated that T. b. brucei is more sensitive than T. cruzi towards the investigated plant extracts (Table 2). The results revealed that the extract of G. erythraea showed activity against T. cruzi (IC50 8.2 μg/ml) and T. brucei (IC50 2.6 μg/ml). Additionally, L. dentata demonstrated activity against T. cruzi and T. brucei with IC50 values of 7.9 and 3.0 μg/ml respectively. Meanwhile, the extract of Tagetes minuta showed less activity against T. cruzi with an IC50 value of 9.2 (SI = 6.9) and higher activity against T. brucei with an IC50 value of 2.2 μg/ml and the highest SI value of >29.1. On the other hand, the methanol extract of P. barbatus, showed antitrypanosomal activity only against T. brucei (IC50 2.6 μg/ml) with high SI value of 12.6, while the extract of V. leopoldii showed activity against both T. cruzi and T. brucei (IC50 9.2 and 8.0 μg/ml) with low SI values of 3.2 and 3.7 respectively.

Cytotoxicity assay

The highest cytotoxic effect against MRC-5 cells was obtained with the methanol extract of Kanahia laniflora (IC50 of 0.83 μg/ml). The extracts of Kniphofia sumarae and Cupressus sempervirens also exhibited a noticeable cytotoxic effect with IC50 values of 7.7 and 10.7 μg/ml respectively (Table 2).

Discussion

The scientific evaluation of medicinal plants used in the preparation of folk remedies has provided modern medicine with several effective pharmaceuticals for the treatment of diseases caused by protozoan parasites [19,20]. As a result of this, during the last two decades numerous studies from various parts of the world on antiprotozoal activity of medicinal plants have been reported [21-26].

In continuation of our search for substances of plant origin with pharmacological effects, we have screened 25 plants collected from Saudi Arabia and Yemen for their antiplasmodial, antileishmanial and antitrypanosomal activities. It is important to mention that at the best of our knowledge, this study represents the first report on antiprotozoal activities for most part of the investigated plants. Although few plants are partly investigated, existing knowledge remains in many cases very limited. Based on the activity (IC50) and selectivity, seven plant extracts could be considered as promising and interesting enough to engage in further purification and evaluation.

During the course of screening, it was found that the methanol extract of the C. oblongifolia, collected from Yemen, exhibited the greatest antiplasmodial activity. Our result is in agreement with data reported recently by Abdel-Sattar et al. (2010) [27], which showed antiplasmodial activity for this species collected from Saudi Arabia (IC50 4.8 μg/ml) with a better selectivity (SI > 13.2). Moreover, Benoit-Vical et al. (2008) [28] reported that the water extract of Chrozophora senegalensis showed a remarkable in vitro antimalarial activity (IC50 1.6 μg/ml).

Other interesting and promising source of antiplasmodial and antitrypanosomal activities is F. ingens. It is worth to mention that this is the first report on the antiprotozoal activity of F. ingens. Other Ficus species like F. citrifoliaF. fistulosa, and F. sur demonstrated a noticeable antimalarial activity [29-31]. Moreover, bioassay-guided fractionation of the extract from the dried leaves and stem barks of F. fistulosa led to the isolation of trichothecene sesquiterpenoids, including verrucarin L acetate which was found to inhibit the growth of P. falciparum with IC50 values below 1 ng/ml [30].

Another interesting plant was G. erythraea, which demonstrated considerable antimalarial and antitrypanosomal activities. Our data are in agreement with literature data of other Grewia species such as G. hexaminta and G. bilamellata[32,33]. Ma et al., (2006) [32] demonstrated that some triterpenoids e.g. 3α,20-lupandiol, grewin, nitidanin and 2α,3β-dihydroxy-olean-12-en-28-oic acid isolated from G. bilamellata are responsible for the antimalarial effect and showed varying degrees of in vitro activity against P. falciparum. The presence of such terpenoids in our G. erythraea may explain the biological effects seen in our screen.

Moreover, one of the most interesting plants was L. dentata collected from Yemen. Our antiparasitic screening revealed remarkable in vitro antiplasmodial and antitrypanosomal activity observed for L. dentata but with moderate SI of 4.1 and 9.8. These findings are in agreement with literature data published recently by Abdel-Sattar et al. (2010) [27] who reported the antiparasitic activity of the methanol extract of L. dentata growing in Saudi Arabia. The extract of L. dentata growing in Saudi Arabia showed better selectivity for P. falciparum (SI = 32.1) as compared with our results. This can be attributed to variation in the area of collection and ecological factors, which has a great impact on the quality and quantity of plants constituents. Apparently the activity of this species is mostly attributed to the presence of essential oil which was revealed to be responsible for antiparasitic and antibacterial activities [34,35].

Tempone et al., (2008) [36] investigated the antileishmanial activity of some Brazilian flora extracts, including P. barbatus which showed activity against L. chagasi with EC50 value of 54.5 μg/ml. In earlier studies, several Plectranthus species showed antiplasmodial activity against P. falciparum 3D7 strain [37,38]. The results obtained in the present screen are in agreement with the literature data found and hence justifies the folkloric use. In addition to that, Van Zyl et al., (2008) [38] attributed the antiplasmodial activity of these Plectranthus species to the presence of abietane diterpenes.

Whereas the crude extract of T. minuta showed a remarkable antitrypanosomal activity against both trypanosome species, no effect was found against P. falciparum. Obviously our results of the antiplasmodial activity of T. minuta were not in agreement with the antimalarial effect noted recently by Lacroix et al., (2011) and Shahzadi et al., (2010) [39,40]. It was demonstrated that the ethyl acetate as well as n-hexane extract exhibited a notable antimalarial activity at 2.78 μg/ml against P. falciparum 3D7 strain. Apparently these findings are attributed to the presence of essential oil as well as sesquiterpene lactones.

In our screen A. bracteosa didn't show any interesting antiprotozoal activity. These results are not in agreement with those recently reported by Chandel and Bagai (2010) [7]. In contrast to several reports on Vernonia species e.g. V. amygdalinaV. brachycalyx.V. cinerea and V. colorata indicating in vitro and in vivo antiplasmodial activity [41-43], our extract of V. leopoldii showed no antiplsmodial activity. On the other hand, V. leopoldii showed a notable antitrypanosomal activity, which was in agreement with the results obtained by Hoet et al. (2004) [44] who attributed the antitrypanosomal activity to the presence of stigmastane-type steroids e.g. vernoguinosterol and vernoguinoside, which were isolated from the stem bark of V. guineensis. Such compounds could also be responsible for the observed effect of V. leopoldii.

Conclusion

In conclusion, the results show that scientific studies carried out on medicinal plants having traditional claims of effectiveness can yield fruitful results. The present work led to the identification of seven plant extracts exhibiting relevant antiprotozoal potential namely C. oblongifolia, F. ingens, G. erythraea, L. dentata, P. barbatus, T. minuta and V. leopoldii. Moreover, the results in the present study support to some extent the traditional uses of some plants for the treatment of parasitic diseases. Studies aimed at the isolation and structure elucidation of antiprotozoal active constituents from some investigated plants are now in progress.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

RAM and NMA carried out the study design, plant collection and extraction, part of the experimental work, data collection and interpretation, literature search and manuscript preparation. AM carried out the in vitro assays, PC and LM evaluated the data and corrected the manuscript for publication. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6882/12/49/prepub

Contributor Information

Nawal M Al-Musayeib, Email: nalmusayeib@ksu.edu.sa.

Ramzi A Mothana, Email: r_mothana@yahoo.com.

An Matheeussen, Email: an.matheeussen@ua.ac.be.

Paul Cos, Email: paul.cos@ua.ac.be.

Louis Maes, Email: louis.maes@ua.ac.be.

Acknowledgements

The authors extend their appreciation to the NPST program by King Saud University for funding the work through the project number (10-MED1288-02). The authors gratefully acknowledge that financial support.

References

  1. World Health Organization. Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. No. 1. 2010.
  2. Nwaka S, Ridley RG. Virtual drug discovery and development for neglected diseases through public private partnerships. Nat Rev Drug Discov. 2003;2:919–928. doi: 10.1038/nrd1230. [DOI] [PubMed] [Google Scholar]
  3. Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941–955. doi: 10.1038/nrd2144. [DOI] [PubMed] [Google Scholar]
  4. Clardy J, Walsh C. Lessons from natural molecules. Nature. 2004;432:829–837. doi: 10.1038/nature03194. [DOI] [PubMed] [Google Scholar]
  5. Tagboto S, Townson S. Antiparasitic properties of medicinal plants and other naturally occurring products. Adv Parasitol. 2001;50:199–295. doi: 10.1016/s0065-308x(01)50032-9. [DOI] [PubMed] [Google Scholar]
  6. Verpoorte R, Choi YH, Kim HK. Ethnopharmacology and systems biology: A perfect holistic match. J Ethnopharmacol. 2005;100:53–56. doi: 10.1016/j.jep.2005.05.033. [DOI] [PubMed] [Google Scholar]
  7. Chandel S, Bagai U. Antiplasmodial activity ofAjuga bracteosaagainst Plasmodium berghei infected BALB/c mice. Indian J Med Res. 2010;131:440–444. [PubMed] [Google Scholar]
  8. Al-Dubai AS, Al-khulaidi AA. Medicinal and Aromatic Plants of Yemen (In Arabic) Sana'a, Yemen: Obadi Center for studies and Publishing; 1996. [Google Scholar]
  9. Atiqur-Rahman M, Mossa JS, Al-Said MS, Al-Yahya MA. Medicinal Plant Diversity in the Flora of Saudi Arabia 1: a Report on Seven Plant Families. Fitoterapia. 2004;75:149–161. doi: 10.1016/j.fitote.2003.12.012. [DOI] [PubMed] [Google Scholar]
  10. Mossa JS, Al-Yahya MA. Al-Meshal I A: Medicinal Plants of Saudi Arabia. Riyadh, Saudi Arabia: King Saud University; 1987. [Google Scholar]
  11. Ali AA, Al-rahwi K, Lindequist U. Some Medicinal Plants Used in Yemeni Herbal Medicine to Treat Malaria. Afr J Trad Complement Altern Med. 2004;1:72–76. [Google Scholar]
  12. Fleurentin J, Pelt JM. Repertory of drugs and medicinal plants of Yemen. J Ethnopharmacol. 1982;6:85–108. doi: 10.1016/0378-8741(82)90073-3. [DOI] [PubMed] [Google Scholar]
  13. Schopen A. Traditionelle Heilmittel in Jemen. Berlin: Franz Steiner Verlag GmbH; 1983. [Google Scholar]
  14. Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: How to develop a strongerin vitroproof-of-concept. J Ethnopharmacol. 2006;106:290–302. doi: 10.1016/j.jep.2006.04.003. [DOI] [PubMed] [Google Scholar]
  15. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Hinrichs DJ. Parasite lactate dehydrogenase as an assay forPlasmodium falciparumdrug sensitivity. Am J Trop Med Hyg. 1993;48:739–741. doi: 10.4269/ajtmh.1993.48.739. [DOI] [PubMed] [Google Scholar]
  16. Hirumi H, Hirumi K. Continuous cultivation ofTrypanosoma bruceiblood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol. 1989;75:985–989. doi: 10.2307/3282883. [DOI] [PubMed] [Google Scholar]
  17. Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R. The Alamar Blue asssay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense, T. b. gambiense)in vitro. Acta Trop. 1997;68:2592–2597. doi: 10.1016/s0001-706x(97)00079-x. [DOI] [PubMed] [Google Scholar]
  18. Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC. Efficient technique for screening drugs for activity againstTrypanosoma cruziusing parasites expressing beta-galactosidase. Antimicrob Agents Chemother. 1996;40:2592–2597. doi: 10.1128/aac.40.11.2592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Phillipson JD, Wright CW. Antiprotozoal agents from plant sources. Planta Med. 1991;57:53–59. doi: 10.1055/s-2006-960017. [DOI] [PubMed] [Google Scholar]
  20. Chan-Bacab MJ, Peña-Rodríguez LM. Plant natural products with leishmanicidal activity. Nat Prod Rep. 2001;18:674–688. doi: 10.1039/b100455g. [DOI] [PubMed] [Google Scholar]
  21. Maes L, Germonprez N, Quirijnen L, Van Puyvelde L, Cos P, Vanden Berghe D. Comparative activities of the triterpene saponin Maesabalide-III and liposomal amphotericin-B (AmBisome) againstLeishmania donovaniin hamsters. Antimicrob Agents Chemother. 2004;48:2056–2060. doi: 10.1128/AAC.48.6.2056-2060.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rocha LG, Almeida JRGS, Macêdo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine. 2005;12:514–535. doi: 10.1016/j.phymed.2003.10.006. [DOI] [PubMed] [Google Scholar]
  23. Chianese G, Yerbanga SR, Lucantoni L, Habluetzel A, Basilico N, Taramelli D, Fattorusso E, Taglialatela-Scafati O. Antiplasmodial triterpenoids from the fruits of neem,Azadirachta indica. J Nat Prod. 2010;73:1448–1452. doi: 10.1021/np100325q. [DOI] [PubMed] [Google Scholar]
  24. García M, Monzote L, Montalvo AM, Scull R. Screening of medicinal plants againstLeishmania amazonensis. Pharm Biol. 2010;48:1053–1058. doi: 10.3109/13880200903485729. [DOI] [PubMed] [Google Scholar]
  25. Wright CW. Recent developments in research on terrestrial plants used for the treatment of malaria. Nat Prod Rep. 2010;27:961–968. doi: 10.1039/c002196m. [DOI] [PubMed] [Google Scholar]
  26. Wube AA, Bucar F, Gibbons S, Asres K, Rattray L, Croft SL. Antiprotozoal activity of drimane and coloratane sesquiterpenes towardsTrypanosoma brucei rhodesienseandPlasmodium falciparum in vitro. Phytother Res. 2010;24:1468–1472. doi: 10.1002/ptr.3126. [DOI] [PubMed] [Google Scholar]
  27. Abdel-Sattar E, Maes L, Salama MM. In VitroActivities of Plant Extracts from Saudi Arabia against Malaria, Leishmaniasis, Sleeping Sickness and Chagas Disease. Phytother Res. 2010;24:1322–1328. doi: 10.1002/ptr.3108. [DOI] [PubMed] [Google Scholar]
  28. Benoit-Vical F, Soh PN, Saléry M, Harguem L, Poupat C, Nongonierma R. Evaluation of Senegalese plants used in malaria treatment: focus onChrozophora senegalensis. J Ethnopharmacol. 2008;28:43–48. doi: 10.1016/j.jep.2007.10.033. [DOI] [PubMed] [Google Scholar]
  29. Antoun MD, Ramos Z, Vazques J, Oquendo I, Proctor GR, Gerena L, Franzblau SG. Evaluation of the flora of Puerto Rico forin vitroantiplasmodial and antimycobacterial activities. Phytother Res. 2001;15:638–642. doi: 10.1002/ptr.880. [DOI] [PubMed] [Google Scholar]
  30. Zhang HJ, Tamez PA, Aydogmus Z, Tan GT, Saikawa Y, Hashimoto K, Nakata M, Hung NV, Xuan le T, Cuong NM, Soejarto DD, Pezzuto JM, Fong HH. Antimalarial agents from plants. III. Trichothecenes fromFicus fistulosaandRhaphidophora decursiva. Planta Med. 2002;68:1088–1091. doi: 10.1055/s-2002-36350. [DOI] [PubMed] [Google Scholar]
  31. Muregi FW, Chhabra SC, Njagi EN, Lang'at-Thoruwa CC, Njue WM, Orago AS, Omar SA, Ndiege IO. In vitroantiplasmodial activity of some plants used in Kisii, Kenya against malaria and their chloroquine potentiation effects. J Ethnopharmacol. 2003;84:235–239. doi: 10.1016/S0378-8741(02)00327-6. [DOI] [PubMed] [Google Scholar]
  32. Ma C, Zhang HJ, Tan GT, Hung NV, Cuong NM, Soejarto DD, Fong HH. Antimalarial compounds fromGrewia bilamellata. J Nat Prod. 2006;69:346–350. doi: 10.1021/np050313d. [DOI] [PubMed] [Google Scholar]
  33. Nguta JM, Mbaria JM, Gakuya DW, Gathumbi PK, Kiama SG. Antimalarial herbal remedies of Msambweni, Kenya. J Ethnopharmacol. 2010;24:424–432. doi: 10.1016/j.jep.2010.01.033. [DOI] [PubMed] [Google Scholar]
  34. Moon T, Wilkinson JM, Cavanagh HM. Antiparasitic activity of twoLavandulaessential oils againstGiardia duodenalis,Trichomonas vaginalisandHexamita inflata. Parasitol Res. 2006;99:722–728. doi: 10.1007/s00436-006-0234-8. [DOI] [PubMed] [Google Scholar]
  35. Mohamed SB, Eddine AD. Antibacterial activity of essential oils of some Algerian aromatic plants against multidrug resistant bacteria. J Essen Oil-Bear Plants. 2010;13:362–370. [Google Scholar]
  36. Tempone AG, Sartorelli P, Teixeira D, Prado FO, Calixto IA, Lorenzi H, Melhem MS. Brazilian flora extracts as source of novel antileishmanial and antifungal compounds. Mem Inst Oswaldo Cruz. 2008;103:443–449. doi: 10.1590/S0074-02762008000500006. [DOI] [PubMed] [Google Scholar]
  37. Lukhoba CW, Simmonds MSJ, Paton AJ. Plectranthus: A review of ethnobotanical uses. J Ethnopharmacol. 2006;103:1–24. doi: 10.1016/j.jep.2005.09.011. [DOI] [PubMed] [Google Scholar]
  38. Van Zyl RL, Khan F, Edwards TJ, Drewes SE. Antiplasmodial activities of some abietane diterpenes from the leaves of fivePlectranthusspecies. S Afri J Sci. 2008;104:62–64. [Google Scholar]
  39. Lacroix D, Prado S, Kamoga D, Kasenene J, Namukobe J, Krief S, Dumontet V, Mouray E, Bodo B, Brunois F. Antiplasmodial and cytotoxic activities of medicinal plants traditionally used in the village of Kiohima, Uganda. J Ethnopharmacol. 2011;133:850–855. doi: 10.1016/j.jep.2010.11.013. [DOI] [PubMed] [Google Scholar]
  40. Shahzadi I, Hassan A, Khan UW, Shah MM. Evaluating biological activities of the seed extracts fromTagetes minutaL. found in Northern Pakistan. J Med Plants Res. 2010;4:2108–2112. [Google Scholar]
  41. Clarkson C, Maharaj VJ, Crouch NR, Grace OM, Pillay P, Matsabisa MG, Bhagwandin N, Smith PJ, Folb PI. In vitroantiplasmodial activity of medicinal plants native to or naturalised in South Africa. J Ethnopharmacol. 2004;92:177–191. doi: 10.1016/j.jep.2004.02.011. [DOI] [PubMed] [Google Scholar]
  42. Pillay P, Maharaj VJ, Smith PJ. Investigating South African plants as a source of new antimalarial drugs. J Ethnopharmacol. 2008;119:438–454. doi: 10.1016/j.jep.2008.07.003. [DOI] [PubMed] [Google Scholar]
  43. Magadula JJ, Erasto P. Bioactive natural products derived from the East African flora. Nat Prod Rep. 2009;26:1535–1554. doi: 10.1039/b906089h. [DOI] [PubMed] [Google Scholar]
  44. Hoet S, Opperdoes F, Brun R, Quetin-Leclercq J. Natural products active against African trypanosomes: a step towards new drugs. Nat Prod Rep. 2004;21:353–364. doi: 10.1039/b311021b. [DOI] [PubMed] [Google Scholar]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BMC

RESOURCES